Roble Belko & Company’s Applied Therapeutics APLT Stock Holding History

Roble Belko & Company’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-65,571	Closed	-$7K	–	446
2025 Q4	$7K	Buy	65,571 +34,730	+113%	+$22.1K	﹤0.01%	326
2025 Q3	$19K	Hold	30,841	–	–	﹤0.01%	235
2025 Q2	$10K	Buy	+30,841	New	+$11.9K	﹤0.01%	267

Roble Belko & Company's APLT Position: Q1 2026 in Review

Roble Belko & Company sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 65,571 shares — an estimated $7K sold.

Roble Belko & Company first reported a position in APLT in Q2 2025 and held it in 3 quarters. The position peaked at $19K in Q3 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Roble Belko & Company reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Roble Belko & Company sold 65,571 Applied Therapeutics shares in Q1 2026, an estimated $7K.
Roble Belko & Company first reported a position in Applied Therapeutics in Q2 2025 and held it in 3 quarters.
Roble Belko & Company's Applied Therapeutics position peaked at $19K in Q3 2025.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Roble Belko & Company's 13F filing for Q1 2026, filed 16 Apr 2026.